Enhanced depth imaging optical coherence tomography findings in Behçet disease

Ocular Immunology and Inflammation

Volumn 21, Issue 6, 2013, Pages 440-445

  Coskun, Erol ^a   Gurler, Bulent ^a   Pehlivan, Yavuz ^a   Kisacik, Bunyamin ^a   Okumus, Seydi ^a   Yayuspayi, Ramazan ^a   Ozcan, Eyup ^a   Onat, A Mesut ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Beh et disease; Choroid; EDI OCT; Retinitis; Uveitis

Indexed keywords

ADULT; ARTICLE; BEHCET DISEASE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL MACULAR THICKNESS; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY; EPIRETINAL MEMBRANE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; REFRACTION ERROR; RETINA ISCHEMIA; RETINA MACULA DEGENERATION; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; SUBFOVEAL CHOROIDAL THICKNESS; UVEITIS; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

ADULT; BEHCET SYNDROME; CHOROID; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; RETINA; RETINITIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; UVEITIS, POSTERIOR; YOUNG ADULT;

EID: 84887962110     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2013.817591     Document Type: Article

References (24)

1. Atmaca LS. Fundus changes associated with behçet' s disease. Graefes Arch Clin Exp Ophthalmol. 1989; 227: 340-344
2. Evereklioglu C. Current concepts in the etiology and treatment of behçet disease. Surv Ophthalmol. 2005; 50: 297-350
3. Tugal-Tutkun I, Cingü K, Kir N, et al. Use of laser flare-cell photometry to quantify intraocular inflammation in patients with behçet uveitis. Graefes Arch Clin Exp Ophthalmol. 2008; 246: 1169-1177
4. Sezen H, Okumus S, Pehlivan Y, et al. Visfatin levels in behçet' s disease. Inflammation. 2012; 35: 405-408
5. Hassenstein A, Meyer CH. Clinical use and research applications of Heidelberg retinal angiography and spectral- domain optical coherence tomography - A review. Clin Exp Ophthalmol. 2009; 37: 130-143
6. Bozzoni- antaleoni F, Gharbiya M, Pirraglia MP, et al. Indocyanine green angiographic findings in behçet disease. Retina. 2001; 21: 230-236
7. Gedik S, Akova YA, Yilmaz G, et al. Indocyanine green and fundus flourescein angiographic findings in patients with active ocular behçet' s disease. Ocul Immunol Inflamm. 2005; 13: 51-58
8. Atmaca LS, Sonmez PA. Fluorescein and indocyanine green angiography findings in behçet' s disease. Br J Ophthalmol. 2003; 87: 1466-1468
9. da Silva FT, Sakata VM, Nakashima A, et al. Enhanced depth imaging optical coherence tomography in longstanding Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2013; 97: 70-74
10. Coşkun E, Okumuş S, Gü rler B, et al. Choroidal thickness in healthy Turkish subjects. Turk J Med Sci., in press
11. Imamura Y, Fujiwara T, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009; 29: 1469-1473
12. Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol. 2009; 147: 644-652
13. Park SC, De Moraes CG, Teng CC, et al. Enhanced depth imaging optical coherence tomography of deep optic nerve complex structures in glaucoma. Ophthalmology. 2012; 119: 3-9
14. Matsuo T, Sato Y, Shiraga F, et al. Choroidal abnormalities in behçet disease observed by simultaneous indocyanine green and fluorescein angiography with scanning laser ophthalmoscopy. Ophthalmology. 1999; 106: 295-300
15. International Study Group for behçet' s Disease. Criteria for diagnosis of behçet' s disease. Lancet. 1990; 335: 1078-1080
16. Mullaney J, Collum LM. Ocular vasculitis in behçet' s disease: A pathological and immunohistochemical study. Int Ophthalmol. 1985; 7: 183-191
17. George RK, Chan CC, Whitcup SM, Nussenblatt RB. Ocular immunopathology of behçet' s disease. Surv Ophthalmol. 1997; 42: 157-162
18. Iaccarino G, Cennamo G, Forte R, et al. Evaluation of posterior pole with echography and optical coherence tomography in patients with behçet' s disease. Ophthalmologica. 2009; 223: 250-255
19. Kaçmaz RO, Kempen JH, Newcomb C, et al Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group. Ocular inflammation in behçet disease: Incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008; 146: 828-836
20. Yu HG, Kim MJ, Oh FS. Fluorescein angiography and visual acuity in active uveitis with behçet disease. Ocul Immunol Inflamm. 2009; 17: 41-46
21. Cingu AK, Onal S, Urgancioglu M, et al. Comparison of presenting features and three-year disease course in Turkish patients with behçet uveitis who presented in the early 1990s and the early 2000s. Ocul Immunol Inflamm. 2012; 20: 423-428
22. Kaburaki T, Araki F, Takamoto M, et al. Best-corrected visual acuity and frequency of ocular attacks during the initial 10 years in patients with behçet' s disease. Graefes Arch Clin Exp Ophthalmol. 2010; 248: 709-714
23. Unoki N, Nishijima K, Kita M, et al. Structural changes of fovea during remission of behçet' s disease as imaged by spectral domain optical coherence tomography. Eye. 2010; 24: 969-975
24. Takeuchi M, Iwasaki T, Kezuka T, et al. Functional and morphological changes in the eyes of behçet' s patients with uveitis. Acta Ophthalmol. 2010; 88: 257-262